2.790USD0.000After-hours 07/31, 20:00 (ET)
131.41KMarket Cap
1.28P/E TTM
Key Figures
1.770Open
1.930High
6.87MVolume
1.28P/E TTM
LossP/E Dynamic
--Dividend TTM
9121.48%Turnover Ratio
4.450Prev. Close
1.610Low
7.29MTurnover
LossP/E Static
0.05P/B
0.00%Div Yield TTM
-272.76%ROA
40.07352wk High
0.26Volume Ratio
-10.62MNet Profit
75.31KShares
1.3622EPS TTM
0.22Beta
-610.42%ROE
0.72852wk Low
7.19%Amplitude
70.08%Gross Margin
131.41KMarket Cap
6.43Reward/Risk
6.42%Risk Rate
Currency: USD Updated: 2026-07-30 Key Insights
Nuwellis Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 128 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Nuwellis Inc Highlights
StrengthsRisks
Nuwellis Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
29
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nuwellis Inc Info
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Ticker SymbolNUWE
CompanyNuwellis Inc
CEOErb (John L)
Websitehttps://www.nuwellis.com/
Shareholders
FAQs
What is the current price of Nuwellis Inc (NUWE)?
The current price of Nuwellis Inc (NUWE) is 1.75.
What is the symbol of Nuwellis Inc?
The ticker symbol of Nuwellis Inc is NUWE.
What is the 52-week high of Nuwellis Inc?
The 52-week high of Nuwellis Inc is 40.07.
What is the 52-week low of Nuwellis Inc?
The 52-week low of Nuwellis Inc is 0.73.
What is the market capitalization of Nuwellis Inc?
The market capitalization of Nuwellis Inc is 131.41K.
Is Nuwellis Inc (NUWE) currently rated as Buy, Hold, or Sell?
According to analysts, Nuwellis Inc (NUWE) has an overall rating of signal_hold, with a price target of 11.00.
What is the Earnings Per Share (EPS TTM) of Nuwellis Inc (NUWE)?
The Earnings Per Share (EPS TTM) of Nuwellis Inc (NUWE) is -888.36.
